Next-generation sequencing of 124 selected cancer-related genes further revealed that concordant mutations (APC, ERBB4, CASP8) exist in tumor and CTCs in addition to TP53. These genes are related to key signaling pathways for cell growth or apoptosis which collectively, might lead to tumor progression and metastasis. The gene discussed is ERBB4; the disease is cancer.